VEGFR
VEGFR (Vascular Endothelial Growth Factor Receptor) inhibitors are compounds that block the signaling of VEGFR, a key receptor in the VEGF pathway, which is crucial for angiogenesis. VEGFR inhibitors prevent the formation of new blood vessels that supply nutrients and oxygen to tumors, thereby inhibiting tumor growth. These inhibitors are widely used in cancer therapy and research to study the mechanisms of angiogenesis and develop anti-cancer treatments. At CymitQuimica, we provide a comprehensive range of high-quality VEGFR inhibitors to support your research in oncology, vascular biology, and angiogenesis.
Found 252 products for "VEGFR".
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
SKLB1002
CAS:Formula:C13H12N4O2S2Purity:>98.0%(HPLC)Color and Shape:White to Light yellow powder to crystalMolecular weight:320.39Axitinib
CAS:Formula:C22H18N4OSPurity:>95.0%(T)(HPLC)Color and Shape:White to Light yellow powder to crystalMolecular weight:386.47NVP-BHG 712
CAS:Formula:C26H20F3N7OPurity:>95.0%(HPLC)Color and Shape:White to Light yellow to Light orange powder to crystalMolecular weight:503.49Sorafenib Tosylate
CAS:Formula:C21H16ClF3N4O3·C7H8O3SPurity:>98.0%(T)(HPLC)Color and Shape:White to Light yellow powder to crystalMolecular weight:637.03Axitinib
CAS:Axitinib (AG-013736) is a multi-targeted tyrosine kinase inhibitor that inhibits VEGFR1/2/3 and PDGFRβ. Axitinib has antitumor activity. Cost-effective and quality-assured.Formula:C22H18N4OSPurity:98.9% - 99.74%Color and Shape:Off-White SolidMolecular weight:386.47Lenvatinib
CAS:Lenvatinib (E7080) is a multi-target receptor tyrosine kinase inhibitor that inhibits VEGFR1-3, FGFR1-4, KIT, PDGFR, and RET, and has oral activity.Formula:C21H19ClN4O4Purity:98.46% - 99.96%Color and Shape:White SolidMolecular weight:426.85Parsatuzumab
CAS:Parsatuzumab (RG 7414), a monoclonal antibody targeting EGFL7, an immunomodulator.Parsatuzumab inhibits the interaction of EGFL7 with endothelial cells.Purity:> 95% - > 95%Color and Shape:Transparent LiquidMolecular weight:148.22 kDaAlbendazole
CAS:Albendazole (SKF-62979) is used as a drug indicated for the treatment of a variety of worm infestations.Formula:C12H15N3O2SPurity:98.21% - 98.76%Color and Shape:Colorless Crystals SolidMolecular weight:265.332H-Indol-2-one, 3-[(3,5-dimethyl-1H-pyrrol-2-yl)methylene]-1,3-dihydro-
CAS:Formula:C15H14N2OPurity:98%Color and Shape:SolidMolecular weight:238.2845Sorafenib tosylate
CAS:Sorafenib tosylate (Bay 43-9006) is a potent multikinase inhibitor (IC50s: 6/20/22 nM for Raf-1/VEGFR-3/B-Raf).Formula:C21H16ClF3N4O3·C7H8O3SPurity:99.24% - 99.94%Color and Shape:SolidMolecular weight:637.03Naphazoline hydrochloride
CAS:Naphazoline hydrochloride (Naphazoline HCl) is an adrenergic vasoconstrictor agent used as a decongestant.Formula:C14H15ClN2Purity:97.93%Color and Shape:White SolidMolecular weight:246.74Lucitanib
CAS:Lucitanib (E-3810) is a VEGFR/FGFR inhibitor targeting VEGFR1-3 and FGFR1-2 with IC50s 7-82.5 nM.Formula:C26H25N3O4Purity:96.13%Color and Shape:SolidMolecular weight:443.49Ref: TM-T15185
1mg46.00€2mg59.00€1mL*10mM (DMSO)90.00€5mg93.00€10mg137.00€25mg255.00€50mg462.00€100mg672.00€Chloropyramine hydrochloride
CAS:Chloropyramine hydrochloride (Alergosan) is a histamine receptor H1 antagonist.Formula:C16H20ClN3·HClPurity:99.45% - 99.83%Color and Shape:White SolidMolecular weight:326.26Pamufetinib
CAS:Pamufetinib (TAS-115) is a potent inhibitor of VEGFR and hepatocyte growth factor receptor (c-Met/HGFR)-targeted kinase.Formula:C27H23FN4O4SPurity:99.39%Color and Shape:White SolidMolecular weight:518.56Ref: TM-T13108
1mg52.00€5mg101.00€1mL*10mM (DMSO)127.00€10mg149.00€25mg244.00€50mg359.00€100mg510.00€200mg695.00€(E)-2-Cyano-3-(4-hydroxy-3,5-diisopropylphenyl)-N-(3-phenylpropyl)acrylamide
CAS:Formula:C25H30N2O2Purity:98%Color and Shape:SolidMolecular weight:390.5179Icrucumab
CAS:Icrucumab, a humanized antibody, inhibits VEGFR-1 and shows antitumor effects, tested in metastatic colon cancer.Purity:> 95%Color and Shape:LiquidMolecular weight:150 kDaPTC299
CAS:PTC299 ((4-chlorophenyl) (1S)-6-chloro-1-(4-methoxyphenyl)-1,3,4,9-tetrahydropyrido[3,4-b]indole-2-carboxylate) is an orally active inhibitor of VEGFA mRNAFormula:C25H20Cl2N2O3Purity:99.72%Color and Shape:White SolidMolecular weight:467.34Ref: TM-T12574
1mg111.00€5mg230.00€1mL*10mM (DMSO)236.00€10mg350.00€25mg590.00€50mg838.00€100mg1,144.00€2-Pyridinecarboxamide,4-[4-[[[[4-chloro-3-(trifluoromethyl)phenyl]amino]carbonyl]amino]-3-fluorophenoxy]-N-methyl-
CAS:Formula:C21H15ClF4N4O3Purity:98%Color and Shape:SolidMolecular weight:482.8154Ref: IN-DA00ICN3
100gTo inquire10mg30.00€50mg46.00€100mg56.00€250mg69.00€500mg100.00€1g131.00€5g255.00€50g617.00€10g619.00€Sunitinib
CAS:Sunitinib (SU 11248) is a multi-targeted receptor tyrosine kinase (RTK) inhibitor that inhibits VEGFR2 and PDGFRβ (IC50=80/2 nM).Formula:C22H27FN4O2Purity:98% - 99.67%Color and Shape:Yellow SolidMolecular weight:398.47Chloramphenicol
CAS:Chloramphenicol (Chloromycetin) is a broad-spectrum antibiotic that inhibits the biosynthesis of bacterial proteins. Cost-effective and quality-assured.Formula:C11H12Cl2N2O5Purity:99.6% - 99.90%Color and Shape:White SolidMolecular weight:323.13Pazopanib
CAS:Pazopanib (GW786034) is an inhibitor of protein tyrosine kinases that inhibits VEGFR1/2/3. Pazopanib has antitumor activity. Cost-effective and quality-assured.Formula:C21H23N7O2SPurity:98.78% - 99.85%Color and Shape:SolidMolecular weight:437.52Sorafenib
CAS:Sorafenib (Bay 43-9006) is a multikinase inhibitor that inhibits Raf-1, B-Raf, VEGFR2, VEGFR3, VEGFR4, PDGFRβ, FLT3, c-Kit, and others (IC50=6/22/90/15/20/20/57Formula:C21H16ClF3N4O3Purity:98% - 99.89%Color and Shape:White SolidMolecular weight:464.82GW806742X
CAS:GW806742X inhibits MLKL with Kd 9.3 μM, preventing necroptosis; also targets VEGFR2.Formula:C25H22F3N7O4SPurity:98.3%Color and Shape:SolidMolecular weight:573.55Sunitinib Malate
CAS:Sunitinib Malate (Sunitinib) is an indolinone-based tyrosine kinase inhibitor.Formula:C26H33FN4O7Purity:98% - 99.26%Color and Shape:SolidMolecular weight:532.56VGX100
VGX100 is a humanized antibody targeting VEGFC for the study of solid tumors.Purity:98.6% (SDS-PAGE); 99.1% (SEC-HPLC) - 98.6% (SDS-PAGE); 99.1% (SEC-HPLC)Color and Shape:LiquidMolecular weight:143.58 kDaATWLPPR Peptide
CAS:ATWLPPR Peptide is a biologically active peptide functioning as a specific antagonist to VEGFR2/KDR.Formula:C40H61N11O9Molecular weight:839.98Abicipar pegol
CAS:Abicipar pegol is an anti-VEGF DARPin for ocular diseases, reducing retinal thickness and leakage.Color and Shape:LiquidTovecimig
Tovecimig is a G1-scFvlh_L-κ type bispecific antibody targeting VEGFA/DLL4.Color and Shape:Odour LiquidConbercept
CAS:Conbercept (KH902) is a fusion protein comprising the second immunoglobulin C-like domain of FLT1 and the third and fourth immunoglobulin C-like domains of KDRPurity:98%Color and Shape:LiquidOlinvacimab
CAS:Olinvacimab (TTAC-0001) is a human monoclonal antibody targeting VEGFR-2/KDR with anti-angiogenic activity that blocks tumor angiogenesis.Purity:97.7% (SDS-PAGE); 97.9% (SEC-HPLC) - 97.7% (SDS-PAGE); 97.9% (SEC-HPLC)Color and Shape:LiquidMolecular weight:148.16 kDaSozinibercept
CAS:Sozinibercept (OPT 302; VGX-300), a VEGFR-3 inhibitor, blocks VEGF-C/D to curb angiogenesis and vascular leakage, and treats rat diabetic retinal edema.Color and Shape:LiquidVEGF-IN-1
VEGF-IN-1 (compound 6) reduces the release of VEGF in U87-MG cells and inhibits angiogenesis in vitro. Additionally, it suppresses cell proliferation by inducing autophagy in tumor cells, with an IC50 value of 28.35 μM against U87-MG cells.Formula:C27H22Cl2N4RuColor and Shape:SolidMolecular weight:574.47Protein LMWP
CAS:Protein LMWP, a cell-penetrating peptide, exhibits inhibitory activity against vascular endothelial growth factor (VEGF), and is utilized in cancer research forFormula:C72H142N44O16Purity:98%Color and Shape:SolidMolecular weight:1880.18GNQWFI
CAS:GNQWFI, an anti-Flt1 peptide, functions as a VEGFR1-specific antagonist. It inhibits interactions between VEGFR1 and various ligands, such as VEGFA, VEGFB, and placental growth factor (PIGF), and suppresses VEGF-induced endothelial cell migration and tubulogenesis. GNQWFI holds potential for research in cancer, asthma, and other ocular diseases.Formula:C37H49N9O9Color and Shape:SolidMolecular weight:763.84KLTWQELYQLKYKGI
CAS:KLTWQELYQLKYKGI (QK) is a VEGF-mimicking peptide that competes with VEGF by binding to its receptors.Formula:C92H143N21O23Purity:98%Color and Shape:SolidMolecular weight:1911.25Hb0025
Hb0025 is a bispecific antibody targeting PD-L1 and vascular endothelial growth factor (VEGF), with EC50 values of 0.67 nM and 0.48 nM, respectively. It exerts antitumor effects by inhibiting VEGF activity and facilitating T-cell infiltration into tumors, thereby transforming the immunosuppressive tumor microenvironment into an immune-activated state. Molecular weight: 170.8 KD.Acrizanib
CAS:Acrizanib (LHA510) is a VEGFR-2 inhibitor, with an IC50 of 17.4 nM for BaF3-VEGFR-2.Formula:C20H18F3N7O2Purity:98.71% - 99.64%Color and Shape:Yellow SolidMolecular weight:445.4Ref: TM-T5373
1mg105.00€5mg260.00€1mL*10mM (DMSO)286.00€10mg401.00€25mg685.00€50mg954.00€100mg1,243.00€Ranibizumab
CAS:Ranibizumab is a humanized monoclonal antibody fragment designed to target and inhibit vascular endothelial growth factor (VEGF), including VEGF110, VEGF121,Purity:98%Color and Shape:LiquidMolecular weight:149.19KDElpamotide
CAS:Elpamotide is a vaccine consisting of a VEGFR2-169 peptide.Formula:C47H76N16O13Purity:98%Color and Shape:SolidMolecular weight:1073.21Arginyl-Glutamine
CAS:Arginyl-Glutamine (Arg-Gln) is a dipeptide nutritional supplement that protects neonatal mice from hyperoxia-induced lung injury, lowering VEGF levels.Formula:C11H22N6O4Purity:95.2%Color and Shape:White SolidMolecular weight:302.33Alacizumab pegol
CAS:Alacizumab pegol (CDP-791), a pegylated antibody fragment targeting KDR, is utilized in cancer research [1].Varisacumab
CAS:Varisacumab (R 84) exhibits high affinity for VEGF-A with an IC50 of approximately 0.3 nM. Varisacumab significantly inhibits endothelial cell proliferation and reduces tumor vascular density in vivo.Color and Shape:LiquidVEGFR-2-IN-55
VEGFR-2-IN-55 (Compound 30) is an effective VEGFR-2 kinase inhibitor with an IC50 of 1.24 nM and exhibits anti-tumor activity.Color and Shape:Odour SolidTyrosine Kinase Inhibitor Library
A unique collection of 1016 tyrosine kinase inhibitors for high throughput screening and high content screening for drug discovery in tyrosine kinase relatedColor and Shape:Odour SolidRef: TM-L2200
1mgTo inquire10μL*10mM (DMSO)To inquire20μL*10mM (DMSO)To inquire30μL*10mM (DMSO)To inquire50μL*10mM (DMSO)To inquire100μL*10mM (DMSO)To inquire250μL*10mM (DMSO)To inquirePulocimab
CAS:Pulocimab, an anti-VEGFR2 monoclonal antibody (mAb), is utilized in cancer research [1].Color and Shape:LiquidMSB-0254
MSB-0254 is a human monoclonal antibody (mAb) that targets VEGFR2/KDR/CD309. It inhibits the invasion, migration, and vasculogenic mimicry (VM) formation of U251 and primary glioma cells. Additionally, MSB-0254 suppresses the growth of U251 and GL261 cell-transplanted tumors. It reduces the expression of CD34, VEGFR2, Ki67, MMP2, MMP9, and CD34/PAS. MSB-0254 is applicable to research on advanced solid tumors.Color and Shape:Odour Liquid
![2H-Indol-2-one, 3-[(3,5-dimethyl-1H-pyrrol-2-yl)methylene]-1,3-dihydro-](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2FIN%2Fthumb-webp%2FDA00298W.webp&w=3840&q=75)
![2-Pyridinecarboxamide,4-[4-[[[[4-chloro-3-(trifluoromethyl)phenyl]amino]carbonyl]amino]-3-fluoroph…](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2FIN%2Fthumb-webp%2FDA00ICN3.webp&w=3840&q=75)
